Skip to main content
. 2004 Sep;42(9):3978–3984. doi: 10.1128/JCM.42.9.3978-3984.2004

TABLE 2.

Antibiotic susceptibilities of A. baumannii clinical isolates

Antibiotica MIC (μg/ml)b
FM0209680 FM0300106 FM0301433
Ampicillin >16 >16 >16
Amoxicillin-CLA 8/4 8/4 16/8
Piperacillin >64 >64 >64
Cefazolin >16 >16 >16
Cefotiam >16 >16 >16
Cefoperazon-SUL ≤16/8 ≤16/8 32/16
Cefotaxime >128 >128 >128
Cefotaxime-CLA 2 8 4
Ceftazidime 8 8 8
Ceftazidime-CLA 1 4 2
Ceftriaxone >64 >64 >64
Cefpirome >16 >16 >16
Cefepime >32 >32 >32
Cefozopran >16 >16 >16
Cefaclor >16 >16 >16
Cefpodoxime >64 >64 >64
Cefoxitin >32 >32 >32
Cefmetazole 32 32 >32
Cefotetan 32 32 16
Flomoxef 16 16 16
Imipenem ≤0.5 ≤0.5 ≤0.5
Meropenem 1 1 1
Aztreonam >64 >64 >64
Gentamicin >8 >8 2
Amikacin 32 >32 16
Minocycline 4 4 4
Levofloxacin 4 4 2
Fosfomycin >16 >16 >16
a

CLA, clavulanic acid at a fixed concentration of 4 μg/ml; SUL, sulbactam.

b

NEG Combo 5J and NEG MIC 5J panels and ESBL plus panel were used for MICs determinations.